tetramethyl Nordihydro<wbr/>guaiaretic Acid

tetramethyl Nordihydroguaiaretic Acid

CAT N°: 70302
Price:

From 23.00 19.55

tetramethyl Nordihydroguaiaretic acid (TMNDGA) is a synthetic derivative of NDGA, a non-selective lipoxygenase inhibitor. It inhibits Sp1 transcription factor binding at the HIV long terminal repeat promoter and at the ?-ICP4 promoter, a gene essential for HSV replication, with IC50 values of 11 and 43.5 µM respectively{16143,16144} TMNDGA induces growth arrest and apoptosis by suppressing Sp1-dependent Cdc2 and survivin gene expression giving rise to its antitumorigenic activity.{16147} The in vivo growth of xenografts in numerous human tumor types was suppressed upon treatment with TMNDGA.{16146} It also inhibits the growth of mouse and human melanomas and human colon cancer in vivo without causing other tissue toxicity.{16145} TMNDGA is currently in Phase I & II clinical trials for treatment of high grade glioma brain tumors.

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View